deltatrials
Not Yet Recruiting OBSERVATIONAL NCT06641934

Current Survey on Chemotherapy-Related Myelosuppression and Clinical Management in Chinese County-level Tumor Patients

Sponsor: Anyang Cancer Hospital

Updated 1 time since 2024 Last updated: Oct 14, 2024 Started: Oct 20, 2024 Primary completion: Oct 20, 2025 Completion: Dec 20, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Myelosuppression and is currently actively recruiting participants. Anyang Cancer Hospital leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Nov 2024 – present · 19 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Anyang Cancer Hospital
  • Army Hospital of the 83rd Army
  • Changyuan People Hospital
  • Hebi People Hospital
  • Henan Hongli Hospital
  • Huojia County Alliance Hospital
  • Huojia County People Hospital
  • Inner Huang County Traditional Chinese Hospital
  • Linzhou People Hospital
  • Puyang Hospital of Traditional Chinese Medicine
  • Puyang Huimin Hospital
  • Qinyang People Hospital
  • The First Affiliated Hospital of Xinxiang Medical College
  • The Second People Hospital of Xinxiang Henan
  • Xinan County People Hospital
  • Xinxiang Central Hospital of Henan province
Data source: The First Affiliated Hospital of Xinxiang Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations